News Focus
News Focus
icon url

biopharm

01/02/18 12:19 PM

#321660 RE: revenue_monster #321659

but the Brekken comments were prior to sunrise being unblinded and referenced in the lab.



Is that what you think the new BODs should think? Hell....if so, looks like some Fiduciary Duties need to be met and that takes time and more time so no worries because as long as shareholders send certified letters of various sorts, clearly pointing things out along the way then it is impossible for any deal to go down, unless for fair value to shareholders.

The new BODs took over with PS Targeting IP in their control and what happens next may make or break their careers in how they handle Fiduciary Duties to shareholders and corporation
icon url

InternetForumUser

01/02/18 12:29 PM

#321661 RE: revenue_monster #321659

Brekken's comments were about as meaningful as Steven King's comments about ASTRONOMICAL value. So far all Bavituximab has proven is that is a great tool for Shareholder Dilution.